Skip to content

SpyGlass Pharma

US · SGP #3415 by market cap Listed 2026
24.30 +0.40 +1.67%
Live - 5344 symbols - heartbeat 394s ago · 2026-10-08 10:03
After-hours 23.90 0.00%
Market cap
812.79M
P/B
3.50
EPS
-1.19
Reader sentiment Are you bullish or bearish on SGP?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Company notice
    Soracom: Commercial availability of the profile management platform "SORACOM Connectivity Hypervisor" has begun, enabling flexible operation of SGP.32‑compatible IoT SIMs.
    JPX · 2026/7/2
  • H.C. Wainwright Maintains SpyGlass Pharma(SGP.US) With Buy Rating, Maintains Target Price $37
    Market Newswire · 2026/10/5
  • Rating change
    H.C. Wainwright Initiates SpyGlass Pharma(SGP.US) With Buy Rating, Announces Target Price $37
    Market Newswire · 2026/3/10
  • Company notice
    Stockland Corp Ltd: Update - Appx 3A.1 Notification of Distribution - SGP
    N/A · 2015/2/11
  • Rating change
    Citi Maintains SpyGlass Pharma(SGP.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/3/10
  • Rating change
    Analysts Offer Insights on NA Companies: SpyGlass Pharma (SGP) and Ottobock SE & Co. KGaA (OBCKF)
    TipRanks · 2026/3/30
  • Stifel Maintains SpyGlass Pharma(SGP.US) With Buy Rating, Maintains Target Price $42
    Market Newswire · 2026/10/2
  • Rating change
    Analysts Offer Insights on NA Companies: Ottobock SE & Co. KGaA (OtherOBCKF), SpyGlass Pharma (Nasdaq: SGP) and Figure Technology Solutions, Inc. Class A (FIGR)
    TipRanks · 2026/8/14
  • Raymond James Initiates SpyGlass Pharma(SGP.US) With Buy Rating, Announces Target Price $39
    Market Newswire · 2026/8/14
  • Company notice
    WonderPlanet Inc: Singapore subsidiary WPBC is Game Changer (SGP) Pte. Ltd. Sign a basic agreement on global regional blockchain game cooperation business
    JPX · 2022/7/13
  • Rating change
    Leerink Partners Initiates SpyGlass Pharma(SGP.US) With Buy Rating, Announces Target Price $42
    Market Newswire · 2026/3/3
  • Rating change
    Jefferies Maintains SpyGlass Pharma(SGP.US) With Buy Rating, Maintains Target Price $62
    Market Newswire · 2026/5/19
  • Rating change
    Citi Initiates SpyGlass Pharma(SGP.US) With Buy Rating, Announces Target Price $42
    Market Newswire · 2026/3/4
  • Analysts Have Conflicting Sentiments on These NA Companies: Fiserv (FISV), SpyGlass Pharma (Nasdaq: SGP) and Evommune, Inc. (EVMN)
    TipRanks · 2026/10/5
  • Company notice
    MATRIX: CIRCULAR TO SHAREHOLDERS IN RELATION TO:- PART A-PROPOSED RENEWAL OF SHAREHOLDERS' MANDATE AND PROPOSED NEW SHAREHOLDERS' MANDATE FOR RECURRENT RELATED PARTY TRANSACTIONS OF A REVENUE OR TRADING NATURE. PART B-(I) PROPOSED ESTABLISHMENT OF A LONG-TERM INCENTIVE PLAN ("LTIP"), COMPRISING THE PROPOSED EMPLOYEES' SHARE OPTION SCHEME ("ESOS") ("PROPOSED ESOS") AND THE PROPOSED SHARE GRANT PLAN
    Bursa Malaysia · 2026/7/27
  • Dentsu Ventures SGP Fund invests in Facilo, a company supporting digital transformation in the real estate industry.
    Dentsu Group · 2026/9/16
  • Rating change
    Jefferies Initiates SpyGlass Pharma(SGP.US) With Buy Rating, Announces Target Price $62
    Market Newswire · 2026/3/3
  • Rating change
    Analysts Offer Insights on NA Companies: BitGo Holdings, Inc. Class A (BTGO) and SpyGlass Pharma (Nasdaq: SGP)
    TipRanks · 2026/3/27
  • Company notice
    Soracom: Jointly developed an IoT SIM card compatible with the next-generation eSIM standard "SGP.32," with phased rollout beginning on July 7.
    JPX · 2026/7/1

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 10:03:04 · For reference only, not investment advice and not tailored to your situation.